Special Issue "The 10th Anniversary of Vaccines—Vaccines against Emerging and Tropical Infectious Diseases"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against (re)emerging and Tropical Infections Diseases".
Deadline for manuscript submissions: 31 December 2022 | Viewed by 600
In 2022, we will celebrate the 10th anniversary volume of the journal Vaccines (ISSN 2076-393X), and we would be thrilled if you could join us on this wonderful occasion.
Vaccines is an international, peer-reviewed, quick-refereeing, open access journal published online by MDPI, Basel, Switzerland. Vaccines is indexed by SCIE, PubMed (NLM), as well as others. The Impact Factor for this journal is 4.961, and it ranks 77/161 (Q2) in “Immunology” and 59/139 (Q2) in “Medicine, Research & Experimental Pharmacology” in Web of Science. The inaugural issue was released in 2013, and in 2020, we published the 1000th paper in this journal. In 2021, we achieved our goal of publishing 1200 papers in one year. Vaccines is definitely a rapidly developing journal.
In recognition of this significant milestone, we are launching a Special Issue entitled “The 10th Anniversary of Vaccines—Vaccines against Emerging and Tropical Infectious Diseases”. This Special Issue will include high-quality papers on topics within the broad scope of Vaccines. We will consider manuscripts that investigate immunology and vaccinology against emerging and tropical infectious diseases, immunological responses to vaccine targets, novel approaches for vaccine development, novel vaccine delivery platforms, novel immunomodulatory adjuvants, role of innate immunity, immune correlates of vaccine efficacy, and evaluation of vaccines using animal models and humans. It is our pleasure to invite you to contribute an original research paper or a comprehensive review article for peer review and possible publication in Vaccines.
Prof. Dr. Nirbhay Kumar
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.